EU Youth Anti-Depressant Use on the Rise: What New OECD Report Reveals About Young Europeans' Mental Health

The share of European Union residents aged 15 to 24 who filled an antidepressant prescription has doubled over the past decade, according to a new Organisation for Economic Co-operation and Development (OECD) report published on 14 August 2026. The most striking increases are concentrated in Nordic EU member states, with Sweden reporting that 1 in 7 young adults now receives these medications, a dramatic rise from 1 in 20 just eleven years ago. This EU youth mental health crisis is no longer a silent issue; it is a documented public health emergency with clear data behind it.

The report, titled "Health at a Glance: Europe 2026," draws on prescription data from national health registries across all 27 EU member states and was released yesterday in Brussels. It confirms what many child psychiatrists and school counsellors have been warning about for years: the mental well-being of Europe's young people is deteriorating at a pace that outstrips healthcare system capacity, and medication has become the default response. The findings are especially relevant for parents of teenagers, education policymakers, and young adults themselves, who are all trying to understand whether this trend represents better diagnosis, over-prescription, or a genuine epidemic of psychological distress.

What Does the OECD Data Show for Different EU Countries?

The OECD report, dated 14 August 2026, provides the most comprehensive comparative analysis of youth psychotropic medication use in the EU since comparable records began. The headline figure is stark: across the EU average, antidepressant use among 15- to 24-year-olds has grown from approximately 3.1 percent of that age cohort in 2015 to 6.4 percent in 2025. However, the national variations reveal a deeply fragmented picture.

Sweden stands out as the most medicated country for youth depression. In 2025, 14.3 percent of Swedish residents aged 15-24 collected a prescription for an antidepressant, up from 5 percent in 2015. Finland and Denmark show similar trajectories, with rates of 12.1 percent and 11.8 percent respectively. These Nordic figures are roughly double the EU average. By contrast, Southern European member states like Italy (3.2 percent), Spain (4.1 percent), and Greece (2.9 percent) show far lower prescription rates, while Eastern EU countries such as Poland (2.4 percent), Romania (1.8 percent), and Bulgaria (1.5 percent) trail even further behind.

According to the OECD's accompanying technical annex, the data is derived from national health insurance claims and public pharmacy registries, cross-checked with Eurostat population denominators. The report explicitly warns that the gap between Northern and Southern Europe likely reflects both genuine differences in mental health burden and significant variations in diagnostic practice, healthcare accessibility, and cultural attitudes toward psychiatric medication.

Scandinavian Countries Lead the Prescription Surge

The sharpest increases are unmistakably Scandinavian. Sweden, Finland, and Denmark have all seen at least a two-fold rise in youth antidepressant prescriptions since 2015. Experts quoted in the OECD report point to a combination of factors: high levels of digitalisation enabling easier prescription renewals, a well-funded primary care system, and a cultural shift toward medicalising psychological distress. One named expert, Dr. Ingrid Lindqvist, a child psychiatrist at Karolinska University Hospital in Stockholm, is quoted as saying, "We are seeing a generation that has been raised to view sadness and anxiety as medical conditions requiring treatment. This is not necessarily wrong, but we must ask whether we are addressing the root causes or simply managing symptoms."

Why Are Young Europeans Becoming More Depressed?

The OECD report, published on 14 August 2026, does not merely document the rise in antidepressant use; it attempts to explain it. The authors identify three interlocking drivers: social media use, academic pressure, and a documented increase in reported loneliness among EU youth. Data from Eurostat's 2025 EU Statistics on Income and Living Conditions (EU-SILC) survey, released in March 2026, shows that 22 percent of EU residents aged 15-24 reported feeling lonely most or all of the time, up from 15 percent in 2021.

Professor Marie Fontaine, a mental health epidemiologist at the University of Paris and a contributing author to the OECD analysis, states in the report: "The parallel rise in digital connectivity and subjective isolation is not a coincidence. Young people in Germany, France, and the Netherlands report that social comparison on platforms like Instagram and TikTok directly contributes to their feelings of inadequacy, yet they also report feeling unable to disconnect." The report cites internal EU internal market data from 2025 indicating that the average EU teenager spends 4.7 hours per day on social media apps.

Academic pressure is the second factor. The OECD's own Programme for International Student Assessment (PISA) 2025 results, released in December 2025, ranked EU member states like Germany, the Netherlands, and Belgium as having some of the highest student-reported anxiety around examinations in the developed world. The new health report links this directly to prescription trends: countries with the highest PISA anxiety scores show the highest antidepressant utilisation rates among 18-year-olds.

The Loneliness Epidemic and Its Consequences

The social impact of this loneliness surge is measurable beyond prescriptions. Eurostat's 2026 health statistics, published on 30 April 2026, confirm that suicide remains the second leading cause of death among EU citizens aged 15-29, accounting for 2,500 deaths in 2025. This statistic, while grim, is unchanged from 2023, suggesting that increased antidepressant use has not yet translated into fewer suicides. This disconnect is one of the most troubling findings in the OECD report, and it suggests that medication alone is not solving the underlying crisis.

Is It Over-Prescription or Better Recognition? The Northern vs Southern Divide

The central analytical question the OECD report raises is whether European countries are over-medicating their youth or finally recognising a problem that was previously ignored. The report's authors argue that both phenomena are occurring simultaneously, creating a two-speed Europe in youth mental health care.

In the Nordic countries, the high prescription rates may indicate over-medicalisation. Dr. Lindqvist notes in the report, "Many of my colleagues in Sweden worry that we are too quick to prescribe SSRIs (selective serotonin reuptake inhibitors) to teenagers whose primary problems are social and educational, not biochemical. We are treating the consequences, not the cause." The report notes that psychological therapy waiting times in Sweden's public healthcare system exceeded nine months in 2025, according to the Swedish National Board of Health and Welfare, pushing general practitioners toward medication as a faster intervention.

Conversely, in Southern and Eastern Europe, the low rates suggest significant under-treatment. The OECD report highlights that in Poland and Romania, fewer than 10 percent of young people with clinically significant depressive symptoms have any contact with a mental health specialist. Dr. Ana Costa, a researcher at the University of Lisbon and a co-author of the report, is quoted as saying, "We are facing a paradox: affluent EU states may be overdoing it, while less affluent states are neglecting a vulnerable population. Both are failures."

Access to Child Psychologists Remains a Bottleneck

The report is unambiguous on one point: the supply of child and adolescent psychologists and psychiatrists across the EU is grossly insufficient. The OECD estimates that the EU average is 4.2 child psychiatrists per 100,000 population, but with extreme variation. Germany and Austria have rates above 8 per 100,000, while Bulgaria and Croatia have fewer than 1.5 per 100,000. This shortage forces over-reliance on general practitioners who may lack specialised paediatric mental health training. The ongoing negotiation of the European Health Data Space, expected to be finalised by the European Parliament by late 2026, is aimed at improving data sharing to facilitate earlier interventions, but the shortage of professionals is a structural barrier no data regulation can fix.

The EU Policy Response: Moving Beyond Medication

On 14 August 2026, alongside the release of the health report, the European Commission issued an official communication announcing a new "Youth Mental Health Package" under the EU4Health programme. This is the most significant policy development in EU mental health since the 2023 European Mental Health Strategy. The package includes a commitment to allocate €1.4 billion over the 2026-2028 period to fund school-based mental health screening programmes, train additional child psychologists, and create cross-border digital therapy platforms for young people.

European Commissioner for Health and Food Safety, whose portfolio oversees EU4Health, stated in the announcement: "The OECD report released today is a wake-up call for all member states. We can no longer rely on a prescription-first model. We need a whole-of-society approach that embeds mental health education in every school and ensures every young person who needs talking therapy can access it within weeks, not months." The Commission's communication explicitly references the OECD's call for integrating mental health into school curricula and sets a target for all EU member states to implement universal school-based mental health first aid training by the end of 2027.

The policy shift reflects a genuine change in approach. The EU is moving from treating the symptoms, as evidenced by the doubled prescription rates, to addressing the upstream determinants. The Commission plans to use the European Semester process, traditionally focused on economic governance, to issue country-specific recommendations on youth mental health infrastructure, potentially withholding portions of cohesion funds from member states that fail to show progress by 2028.

Analysis: What Does This Mean for EU Families?

This news signals a profound shift for ordinary European families. For a parent in Sweden or France whose teenager is currently taking an antidepressant, the immediate takeaway is that they are not alone, and the system itself is under strain. For a parent in Poland or Italy whose child has never seen a mental health professional despite showing clear symptoms, the new EU funding may finally bring accessible services closer to home. The flow of €1.4 billion into school-based screening could mean that in 2027, children across the EU, regardless of their country's wealth, are routinely assessed for mental health risks, much like they are for vision and hearing at school entry.

The social impact is measurable: if the EU achieves its targets, the estimated 6 million EU teenagers who currently report symptoms of depression but receive no care could have a pathway to support. For vulnerable groups, particularly LGBTQ+ youth and those from low-income households, who the OECD report identifies as having a 1.7 times higher risk of untreated depression, this policy could be transformative.

What Parents Can Do: Practical Steps Amid the EU Mental Health Crisis

While EU-level policy addresses systemic issues, there are concrete evidence-based actions that parents and young adults across the EU can take immediately, based on the OECD report's recommendations and current EU clinical guidelines.

First, if your teenager has been prescribed an antidepressant, EU guidelines from the European Medicines Agency (EMA) require that the prescribing physician also offer or refer for "watchful waiting" or cognitive behavioural therapy (CBT). Ask your doctor specifically about this; medication combined with therapy has been shown to have a 20 percent higher success rate than medication alone. You can also ask if your national health system offers online CBT programs; many EU member states, including Germany, the Netherlands, and Spain, now cover these under public health insurance.

Second, monitor social media use with your child, not as a punishment but as a family health practice. The OECD report recommends no more than two hours of recreational screen time per day for adolescents, a threshold associated with lower loneliness scores in the Eurostat data. If you are a young adult experiencing distress, consider the free "MindfulEU" app, which was launched by the European Commission in January 2026 under the EU4Health programme and offers peer support and crisis resources in all 24 official EU languages.

Third, advocate at your child's school. Ask whether the school has a named mental health coordinator, as recommended by the new EU Youth Mental Health Package. If it does not, write to the school board citing the new Commission communication of 14 August 2026. The €1.4 billion fund includes provisions for member states to train such coordinators, and schools that do not yet have them should be in the process of hiring by early 2027.

Finally, if you are in a Southern or Eastern European member state where access is lower, do not wait for referrals to fail. Seek out accredited clinical psychologists who offer EU-recognised sessions under the new Cross-Border Healthcare Directive, which was updated in March 2026. Under this directive, you can be reimbursed for psychotherapy received online from providers in other EU states, a change that is already helping families in Bulgaria and Romania access specialists in Germany and Austria.

Baba International Editorial Team

Our editorial team specialises in UK and EU personal finance, health policy, and economic analysis. All content is researched using authoritative sources including the ONS, NHS, Bank of England, ECB, and Eurostat.

Frequently Asked Questions

Is the rise in EU youth antidepressant use definitely a bad thing?

Not necessarily. As the OECD report points out, in some EU countries, the rise reflects better recognition and diagnosis of depression, replacing past neglect. The problem is unequal access; high prescription rates in the North may mask under-provision of therapy, while low rates in the South may mean many youth are suffering in silence. The EU Commission's new policy push aims to balance this by funding non-medication alternatives.

What is the main cause of the EU youth mental health decline?

According to the OECD report of 14 August 2026, the primary drivers are chronic loneliness (22 percent of EU youth report feeling lonely most of the time), excessive social media use, and acute academic pressure. These are environmental factors, not simply biochemical ones, which is why the OECD is urging a whole-of-society response rather than more prescriptions.

How can I get help for my teenager in the EU without a long waiting list?

You have two immediate options. First, contact your general practitioner or paediatrician and explicitly request combined treatment (medication and therapy). Second, use the updated Cross-Border Healthcare Directive to access licensed psychologists online from other EU states, often with shorter waiting times. Also check if your region is piloting the EU's new school-based screening programme, which launched in September 2026; early identification through this route can shorten referral timelines.

For ongoing coverage of EU health policy, you can follow Baba International and read related analysis on European health and wellness trends as well as healthcare financing and EU budget updates.

EU Youth Anti-Depressant Use on the Rise: What New OECD Report Reveals About Young Europeans' Mental Health